NIH-funded research R01 grant

HIV-associated hypertension: how HIV proteins may drive high blood pressure

Official title: Mechanisms of HIV-associated Hypertension

Funded at Augusta University · NIH-11398022 · Data updated 2026-11-12

This NIH grant explores how residual HIV proteins could contribute to high blood pressure in people living with HIV, using animal models to understand the link to heart and blood vessel health.

More Hypertension research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAugusta University
NIH-funded
Lab location1 site (Augusta, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2028
Funding year2026
Award (this year)$669,900
NIH project number5R01HL175471-03
Project IDNIH-11398022 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with HIV who may be at higher risk for cardiovascular disease, or patients with related inflammatory or vascular conditions who could benefit from future therapies guided by this work.

Less likely to help

People without HIV or without cardiovascular risk factors may not directly benefit from this research.

What this research studies

Researchers will study whether HIV components that linger in the body after treatment promote blood pressure increases, vascular dysfunction, and inflammation. They use a mouse model that carries HIV proteins and also test what happens when immune cells are altered, to see if blood pressure and heart health improve. The work combines measurements of blood pressure, blood vessel relaxation, and immune signals to map the pathway from HIV proteins to hypertension. Findings could highlight new targets to prevent cardiovascular disease in people with HIV. The study is conducted at Augusta University under a team led by Dr. Eric J. Belin de Chantemele.

Why it matters

Potential benefit: If successful, the research could identify mechanisms linking HIV to hypertension and point to new strategies to prevent cardiovascular disease in people living with HIV.

How similar studies have gone: Preliminary data in this model suggest a link between HIV proteins, inflammation, and hypertension, with early evidence of a causal pathway.

Where this research is happening

  • Augusta University
    Augusta, United States
    Active

Researchers

  • Principal investigator: Belin de Chantemele, Eric J — Augusta University
  • Study coordinator: Belin de Chantemele, Eric J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.